MDS Pharma Services Names Dr. Lori McDonald to Executive Leadership Team
26 Juin 2008 - 3:00PM
PR Newswire (US)
Experienced leader will head Quality & Compliance function at
leading contract research organization KING OF PRUSSIA, PA, June 26
/PRNewswire-FirstCall/ -- MDS Pharma Services, a leading provider
of innovative drug discovery and development solutions, has hired
Dr. Lori McDonald as Vice President, Quality & Compliance. Dr.
McDonald will lead MDS Pharma Services' ongoing program to build
and manage quality and regulatory compliance systems across its
global business platforms. "I'm delighted that Dr. McDonald has
joined our leadership team," said MDS Pharma Services President
David Spaight. "By enabling process improvements and compliance
with regulatory requirements, she and her staff will be
instrumental in helping MDS Pharma Services deliver high-quality,
on-time services. This will help our clients expedite their drug
discovery and development programs." Dr. McDonald brings strong
credentials to this key leadership position. Before joining MDS she
served as Vice President, Regulatory Affairs with Alder
Biopharmaceuticals. From 2001 to 2006, Dr. McDonald held a series
of leadership roles with Cardinal Health, culminating as Executive
Director, Regulatory Affairs. Prior to that, she worked at Ligand
Pharmaceuticals and Abbott Laboratories. Dr. McDonald holds a B.S.
in Medical Technology from the University of North Dakota, and both
an M.S. and a Ph. D. in Pharmaceutics from the University of
Michigan. She also holds a Regulatory Affairs Certification, which
is administered by the Regulatory Affairs Professionals Society.
About MDS Pharma Services MDS Pharma Services is committed to
delivering quality service on time. We offer a full spectrum of
resources to meet the drug discovery and development needs of the
pharmaceutical and biotechnology industries. With numerous
facilities strategically located around the world, we apply
advanced scientific and technological expertise throughout the drug
discovery and development process - from lead optimization, pre-IND
research, early clinical research (bioequivalence, phases I-IIa)
and bioanalysis through to global clinical development (phases
IIb-IV), central lab and centralized cardiac services. For more
information, visit our website at http://www.mdsps.com/. MDS Pharma
Services is a business unit of MDS Inc. (TSX: MDS; NYSE: MDZ), a
global life sciences company that provides market-leading products
and services that our customers need for the development of drugs
and diagnosis and treatment of disease. We are a leading global
provider of pharmaceutical contract research, medical isotopes for
molecular imaging, radiotherapeutics, and analytical instruments.
MDS has more than 5,500 highly skilled people in 29 countries. Find
out more at http://www.mdsinc.com/ or by calling 1-888-MDS-7222, 24
hours a day. DATASOURCE: MDS Pharma Services CONTACT: For
Investors: Kim Lee, (416) 675-6777 ext. 34721, ; For Media:
Charlene McGrady, (610) 239-7900 ext. 231,
Copyright